The update of the AlsterResearch study on the Geratherm Group, published on June 29, 2023, once again confirms the price target of EUR 11.30 with a clear buy recommendation. The reasons for this are in particular the strong growth at the end of 2022, the strong EBIT improvement and the good outlook for 2023.
Via Research Hub, investors get free access to the update of Geratherm Medical's digital coverage.
Alternatively, you can find the update as a PDF file here.
